Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Peter

Showing results (181-190 of 261) with videos related to

Pageof 27
Sort By:
Diabetes|February 5, 2013
Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humansRobert Wagner, Gabriele Kaiser, Felicia Gerst, et al.
Nature Medicine|January 5, 2021
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetesRobert Wagner, Martin Heni, Adam G Tabák, et al.
Journal of Clinical Medicine|November 26, 2022
Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate CancerStefan Zoltán Lutz, Jörg Hennenlotter, Andras Franko, et al.
Journal of Personalized Medicine|September 16, 2020
Transcript Levels of Aldo-Keto Reductase Family 1 Subfamily C (AKR1C) Are Increased in Prostate Tissue of Patients with Type 2 DiabetesAndras Franko, Lucia Berti, Jörg Hennenlotter, et al.
Biomedicines|November 19, 2020
Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 DiabetesAndras Franko, Lucia Berti, Jörg Hennenlotter, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 17, 2025
Elevated Cholinesterase Activity and the Metabolic Syndrome-Dissecting Fatty Liver, Insulin Resistance and DysglycaemiaMartin Heni, Julia Hummel, Louise Fritsche, et al.
Diabetologia|July 3, 2026
Unhealthy fat distribution as a sex-specific predictor of declining hippocampus insulin sensitivityLeontine Sandforth, Ralf Veit, Jürgen Machann, et al.
Diabetes, Obesity & Metabolism|February 28, 2018
Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trialKonstantinos Kantartzis, Louise Fritsche, Maria Bombrich, et al.
Frontiers in Endocrinology|July 17, 2023
Atrial natriuretic peptide and leptin interactions in healthy menMartin A Daniels, Pamela Fischer-Posovszky, Michael Boschmann, et al.
Diabetes|April 13, 2026
Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP StudyCaroline Z Meier, Robert Wagner, Marlene Ganslmeier, et al.
Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
Diabetes|February 5, 2013
Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humansRobert Wagner, Gabriele Kaiser, Felicia Gerst, et al.
Nature Medicine|January 5, 2021
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetesRobert Wagner, Martin Heni, Adam G Tabák, et al.
Journal of Clinical Medicine|November 26, 2022
Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate CancerStefan Zoltán Lutz, Jörg Hennenlotter, Andras Franko, et al.
Journal of Personalized Medicine|September 16, 2020
Transcript Levels of Aldo-Keto Reductase Family 1 Subfamily C (AKR1C) Are Increased in Prostate Tissue of Patients with Type 2 DiabetesAndras Franko, Lucia Berti, Jörg Hennenlotter, et al.
Biomedicines|November 19, 2020
Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 DiabetesAndras Franko, Lucia Berti, Jörg Hennenlotter, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 17, 2025
Elevated Cholinesterase Activity and the Metabolic Syndrome-Dissecting Fatty Liver, Insulin Resistance and DysglycaemiaMartin Heni, Julia Hummel, Louise Fritsche, et al.
Diabetologia|July 3, 2026
Unhealthy fat distribution as a sex-specific predictor of declining hippocampus insulin sensitivityLeontine Sandforth, Ralf Veit, Jürgen Machann, et al.
Diabetes, Obesity & Metabolism|February 28, 2018
Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trialKonstantinos Kantartzis, Louise Fritsche, Maria Bombrich, et al.
Frontiers in Endocrinology|July 17, 2023
Atrial natriuretic peptide and leptin interactions in healthy menMartin A Daniels, Pamela Fischer-Posovszky, Michael Boschmann, et al.
Diabetes|April 13, 2026
Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP StudyCaroline Z Meier, Robert Wagner, Marlene Ganslmeier, et al.
Pageof 27